Thyrocare Technologies: SEBI Takeover Regulation 31 Disclosure Filed
The disclosure was formally submitted to NSE on 18 August 2026 under SEBI's takeover regime. Regulation 31 of SEBI (SAST) Regulations, 2011 mandates disclosure by the target company within two days of acquisition of shares triggering the threshold. No public details on bidder, offer price, shareholding, or transaction consideration are accessible at this stage.
Why it mattersRegulation 31 filing signals crossing of 25% threshold or formal open-offer commencement; transaction architecture and structuring details are gated pending full offer document publication and SEBI review.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object]
Sources
- NSE Corporate Archives · official
Related deals
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Trilegal acts on Berry Street - Healthify merger27 Aug 2026
- ChrysCapital-backed KIMS in talks to acquire minority stake in Renova Hospitals for $52M25-26 Aug 2026 · $52 million
- Mankind Pharma Limited: Other Restructuring26 Aug 2026
- Mankind Pharma Limited: Outcome of Board Meeting26 Aug 2026